Transfusion medicine and Blood safety: Policy, Diagnostics and Standards development |
Mike Busch, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Transfusion Medicine, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening |
|
|
Drug Resistant Malaria Clinical and Laboratory Studies |
|
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Host Protein Degradation by Schistosome Parasites |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Proposed Experiments to Study Emergence of Antimicrobial Resistance in Methicillin- Resistant Strains of Staphylococcus aureus |
Henry Chambers, MD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Applied Research on Antimicrobioal Resistance: Molecular Epidemiology of Community Methicillin-resistant Staphylococcus aureus (MRSA) |
Henry Chambers, MD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Hemin Receptor Gene Family of Bartonella quintana |
|
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Genomic and Clinical Correlates of Human Bartonella Quintana Infection |
|
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Targeting Cysteine Proteases--Antiparasitic Chemotherapy |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Enfuvirtide Intensification for Multi-Drug Resistant HIV |
Steven Deeks, MD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment |
|
|
Translational Studies of Antimalarial Drug Resistance |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Cap Independent Translation of Dengue Virus |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Valley Fever Vaccine Project |
George Rutherford, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development |
|
|
High Throughput Assay for Screening Compounds Against T. Brucei |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Optimization of Cysteine Protease Inhibitors Targeting Trypanosoma Brucei |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Schistosoma mansoni: Identification and Validation of New Targets for Therapy Using a siRNA Screen |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Transcriptional Responses of Parasite and Host during Intestinal Colonization and Invasion by Entamoeba histolytica |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Predicting and Improving Critical Outcomes for Bacterial Keratitis |
Nisha Acharya, MD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness |
|
|
Predicting and Improving Outcomes in Bacterial and Fungal Keratitis |
Nisha Acharya, MD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness |
|
|
UCDRD Whitepaper: Viral Pathogens |
Joseph Derisi, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance |
|
|
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) |
Henry Chambers, MD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection |
|
|
Bartonella Virulence Mechanisms in Patients with AIDS |
|
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS |
|
|
Trypanosome Drug Development Consortium |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129 |
Henry Chambers, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Epidemiology and Surveillance |
|
|
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Janssen/Sakanari - flubendazole study 20150930 |
Judy Sakanari, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
HIV Emergence of Drug Resistance |
|
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment |
|
|
The Incidence of Bacillary Angiomatosis in Uganda |
|
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection |
|
|
Virus population dynamics, genetic diversity and evolution |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Detection and Discovery of Viral Pathogens Associated with Dengue-like Symptoms in Nicaragua |
Joseph Derisi, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance |
|
|
Core B: Intracellular Pathogens and Innate Immunity |
Joseph Derisi, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Regulation of the Development of Trypanosoma brucei |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Prevention of Emergence of Antibiotic Resistant P. aeruginosa |
|
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Microbial Pathogenesis and Host Defense |
Joanne Engel, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Training International Scholars and Clinicians |
|
|
Utility of Contact Investigation of Drug Susceptible and Resistant Tuberculosis in Tanzania |
Elizabeth Fair, PhD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Epidemiology and Surveillance |
|
|
Identification of Anti-HIV Lead Compounds Targeting |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS |
|
|
CDC Preparedness and Emergency Response Research Center |
Travis Porco, PhD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Subcontract Work in Association with LLNL LDRD Project: COMP-08ERD036 |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Quasispecies and drug resistance |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Valley Fever Vaccine Project 2010 |
George Rutherford, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development |
|
|
Student and Postdoctoral Collaborations Travel Award |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Residencies, Fellowships, and Postdoctoral Training |
|
|
Bartonella henselae: Mechanisms of Chronic Bloodstream Infection |
|
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Comprehensive Diagnostics for Viral Encephalitis/Meningitis |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Comprehensive Diagnostics for Viral Encephalitis/Meningitis |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Expanded Access to MGAWN1 in Subjects with Suspected West Nile Neuroinvasive Disease; Substantial Exposure, or Infection and a Compromised Immune System |
Jeffrey Ralph, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Pharmacology and Drug Treatment |
|
|
Tuberculosis guidelines and best practices internationally |
Sarah Royce, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis |
|
|
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Iron-Dependent Drug Delivery as a New Paradigm in Anti-Parasitic Chemotherapy and Prophylaxis |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Programmable Genetic Memory in Bacteroides: Diagnosis of Diarrheal Disease |
|
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Pediatrics, Newborn and Infant Health |
|
|
Genetics of Brazilian Populations |
Mark Seielstad, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance |
|
|
Systems-Based Analysis of Flaviviral Host Restriction |
Nevan Krogan, PhD, MSc |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Chemical Methods for Ferrous Iron Targeted Drug Delivery |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Viral Discovery in Human and Animal Samples |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Structure-Aided Design of CYP51 Inhibitors for Treatment of Parasitic Infections |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
A New Field Assay to Diagnose and Monitor Schistosomiasis |
|
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Vitamin A Metabolism and Helminth Infection |
Mike McCune, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Linking Virus Population Genetic Structure to Infectivity and Adaptation |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Multiplexed Viral and Cytokine Response Assays Using NanoString Technology |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
California Emerging Infections Program |
Ina Park, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance, Health Systems Strengthening, UCSF Professional Education |
|
|
Using Pan-Pathogen Microarrays and Deep Sequencing to Search for the Cause of Southern Tick-Associated Rash Illness (STARI) |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
The PIP2-Virus Interface and PI 4-Kinase: Novel Biology and Validation Targets |
Kevan Shokat, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Trefoil Factors Regulate Th2 Immunity |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Immunology |
|
|
Host-pathogen Interactions during Vertical Transmission of Listeria monocytogenes |
|
Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Women's Health, Labor and Delivery, Newborn and Infant Health |
|
|
Trial of T.cruzi DNA Vaccine in Experimental Model of Disease Challenge Infection |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Designing Selective Inhibitors of Calcium-Dependent Kinases in Parasites |
Kevan Shokat, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Novel Mechanisms of Beta-Lactam Resistance in Staph aureus |
Henry Chambers, MD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Clin 0004 Characterization of Viral Hemorrhagic Fevers of Unknown Origin |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Clin 0003 Identification and Characterization of a Putative Novel Poxvirus in the DRC |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Identification of Signaling Pathways Associated with Lyme Disease |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
HARC Center: HIV Accessory and Regulatory Complexes |
Alan Frankel, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Immunology |
|
|
Pathogen Discovery in PREDICT Human and Wildlife samples to Detect and Identify Viruses Present, Both Known and Novel |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Regulation of Virulence Traits in a Fungal Pathogen of Cancer Patients |
|
Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease |
|
|
Identifying inhibitors of Parasitic Worm Activity |
|
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
C. elegans as a Targeted Molecular Surrogate for Filarid Parasites 2 |
Kaveh Ashrafi, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Broad Spectrum Antivirals Targeting Envelope Proteolysis and Viral Uncoating |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Antibacterial Resistance Leadership Group (ARIG) |
Henry Chambers, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Systematic Reviews and Guideline Development |
|
|
2013 NIH Workshop on Protein Homeostasis and Viral Infection |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance |
|
|
A schistosome cysteine protease in Th response polarization |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Identification and Validation of Targets of Phenotypic High Throughput Screening |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Kinetoplastid Drug Development: Strengthening the Preclinical Pipeline |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Harvesting of S. Mansoni schistosoma eggs |
|
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Non-invasive diagnosis of viable adult filarial infections |
Judy Sakanari, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB In Vivo |
Payam Nahid, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Fighting emerging antimalarial drug resistance |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Chlamydial sexually transmitted diseases and trachoma |
Deborah Dean, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Predictors of Cardiomyopathy Progression in a Cohort of Bolivian Patients with Chagas Disease |
Caryn Bern, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Cardiovascular Disease |
|
|
International Clinics on Infectious Disease Dynamics and Data (ICI3D Program) |
Travis Porco, PhD, MPH |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Training International Scholars and Clinicians |
|
|
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
De Facto Monotherapy during Multidrug Tuberculosis Treatment and Emergence of Resistance |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic |
Kevan Shokat, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Interaction between Innate and Th2 Lymphocytes in Helminth Immunity |
Jesse Nussbaum, MD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Travel Medicine in Global Health |
Mary Wilson, MD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Trefoil Factor Proteins Modulate Host Immunity against Hookworms |
|
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Lead Identification to Clinical Candidate Selection: Drugs for Chagas' Disease |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Epidemiology of leishmaniasis and schistosomiasis |
Donald Heyneman, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Immunology & epidemiology of intestinal infectious diseases |
Robert Owen, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Epidemiology and Surveillance |
|
|
Serological prevalence of viral hemorrhagic fevers in Equatorial Africa |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Analysis of the rapid policy change toward empirical treatment of fever with artemisinin-based combination therapy in Ebola-burdened areas of Liberia |
Matt Susko, MS |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Policy and Standards of Care |
|
|
Sanitation, Water, and Instruction in Face-washing for Trachoma (SWIFT) |
Jeremy Keenan, MD, MPH |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness |
|
|
Metabiota - Viral Surveillance for the PREDICT Program 20150410 |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Pathogen characterization and discovery by deep sequencing of two major vectors associated with Lyme disease and other tickborne infections |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Processing Uganda Swabs for Trachoma Alternative Indicators Study |
Julius Schachter, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness |
|
|
Targeting host autophagy for treating Mtb infections and synergizing with antibiotics in vivo |
|
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment |
|
|
Resistance of Malaria Parasites to Artemisinin-Based Therapies |
Philip J. Rosenthal, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Auranofin supplies to test as a macrofilaricide for human onchocerciasis |
Jaime Sepulveda, MD, DSc, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Philippine-UC Collaboratory for Device Innovation (Education/Training Award) |
Michael Harrison, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Drug and Diagnostics Development, Genetics, Training International Scholars and Clinicians |
|
|
RAPID: Ebola virus population structure, genetic diversity and evolution |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Quantitative mapping of interactions between dengue virus and its hosts |
|
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
CCD Study- RNA Sequencing |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Optimal MDR treatment in children |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Gene circuits that control morphology in Histoplasma |
Anita Sil, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection |
|
|
Prevalence of baseline and longitudinal heteroresistant M. tuberculosis and association with patient-important outcomes |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Identifying the role of opportunistic pathogens including Giardia, Cryptosporidia, Microsporidia and Mycobacterium avium |
Robert Owen, MD |
Opportunistic Infection, Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease |
|
|
Disease susceptibility and global distribution of genetic variation |
Mark Seielstad, PhD |
HIV/AIDS, Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance |
|
|
Real-Time Detection of Bloodborne Pathogens by Unbiased Nanopore Sequencing 20150506 |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus, Continuation A120553 |
Henry Chambers, MD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Naturally acquired immunity to norovirus in a newborn cohort in Peru |
Caryn Bern, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Newborn and Infant Health |
|
|
Novel methods for monitoring long-term drug exposure and resistance amplification during treatment of multidrug resistant tuberculosis |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Treating Snake Envenomation in India: A Costing Analysis for the Adoption of a Small Molecule Therapeutic |
Simran Dhanju, MS |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Host-Directed Strategies to Create Synergistic Antibacterial Therapies |
|
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development, Immunology |
|
|
New approaches to study Pseudomonas-host interactions |
Joanne Engel, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Profiling of Collaborator's Small Molecule Anti-filarials |
Judy Sakanari, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Development of the infant gastrointestinal virome and shedding of oral polio and rotavirus vaccines in Bangladeshi and US infants |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Newborn and Infant Health |
|
|
The Impact of WASH on Re-infection with STH |
Jeremy Keenan, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Epidemiology and Surveillance, Risk Reduction and Prevention |
|
|
Epidemiology of vector borne diseases |
Isabel Rodriguez Barraquer, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance |
|
|
Bartonella: dissecting niche-specific adaptation in a human pathogen |
|
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Phase 1 Train of Na-APR-w and Na-GST-1 Hookworm Vaccine in Brazilian Adults |
Bryan Greenhouse, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Mass Treatment of Soil-Transmitted Helminths as a Platform for National Cooperation and Action in Peru: |
Xochilt Borja, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Health Economics and Effectiveness |
|
|
he Efficacy of Various Antibiotics at Targeting Wolbachia for the Treatment of Lymphatic Filariasis |
Emma Gunderson, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Sustained Strengthening of Public Health Laboratory, Transfusion Services and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia |
Kayla Enriquez, MD, MPH |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Drug and Diagnostics Development, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening, Training International Scholars and Clinicians |
|
|
Fellowship - Award - 2016-2017 Pathogenesis and Treatment of Ebola-Associated Uveitis Rationale |
Nisha Acharya, MD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Eye Disease and Blindness |
|
|
Snakebite treatment in Nepal |
Tommaso Bulfone, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Selective AAK1 and GAK inhibitors for combating Dengue and other emerging viral infections |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Novel Therapeutics for Treatment of River Blindness and Lymphatic Filariasis |
Judy Sakanari, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Vertical Transmission of Zika Virus: Placental Histopathology and Fetal Outcomes |
Stephanie Valderramos, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neurology and Mental Health, Newborn and Infant Health |
|
|
UC Valley Fever Research Initiative |
Anita Sil, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Genetics |
|
|
Pathogen discovery and epidemiology in tick vectors associated with Lyme-like diseases |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
INTERCEPT: Interfering and Co-evolving Prevention and Therapy |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
International Clinical Research Fellowship |
Christopher Stewart, MD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training |
|
|
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal |
Grant Dorsey, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Epidemiology and Surveillance |
|
|
A Combined Pathogen-Host Sequencing Assay for Diagnosis of Lyme and Other Tickborne Infections |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Drug-Resistant Tuberculosis on the Texas-Mexico Border: Improving the Quality of bi-national TB Projects |
Camila Hurtado, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis |
|
|
Understanding the Effects of Snake Envenomation in Livestock on the Lives of Farmers in the Southern Pacific Region of Costa Rica |
Andrea Nickerson, MS |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Whole Genome Sequence Characterization of Drug Resistant Malarial Strains |
Sumayya Mohammed, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Genetics |
|
|
Community Perceptions of Intestinal Infections in the Sorsogon Province, the Philippines |
Ekaterina Tangog , MS |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Attitudes and Perceptions of a Musical Intervention "Iculo Ngenyoka" for Snakebite Awareness in Swaziland: A Qualitative Study |
Liam Erickson, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Patient and Peer Education |
|
|
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting with Community Acquired Pneumonia (CAP) in Endemic Areas (FLEET-Valley Fever) |
Mohamed Fayed, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance |
|
|
The impact of antimalarial resistance on malaria transmission in Uganda |
Melissa Conrad, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria |
|
|
Leveraging mosquito antiviral immunity to detect viral infections: Towards a scalable field-based approach for predicting arbovirus epidemics |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Building Evidence for Advancing New Treatment For XDR/XDR-TB (BEAT TUBERCULOSIS) Study |
Patrick Phillips, PhD, MS, MA |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Pharmacology and Drug Treatment |
|
|
The M-PulSe Study: Detecting Pulmonary Edema in Sepsis with Lung Ultrasonography in Malawi |
Richard J. Wang, MD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance |
|
|
How Zika virus disrupts neuronal cellular architecture |
Jeremy Reiter, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Dissecting the effect of paracrine responses to Zika virus on neurodevelopment in the human brain |
Hanna Retallack, AB |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
HPMI: Host Pathogen Mapping Initiative |
Nevan Krogan, PhD, MSc |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Genetics |
|
|
The impact of vector control interventions on adverse birth outcomes. |
Michelle Roh, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Women's Health, Newborn and Infant Health |
|
|
Insect adaptive immunity |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance |
|
|
PREDICT-2 |
Dean Jamison, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Risk Reduction and Prevention |
|
|
Chagas |
Caryn Bern, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Visceral leishmaniasis control in India |
Caryn Bern, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs) |
|
|
Simcere Surpi eval project |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Host-pathogen interactions: Unveiling common mechanisms for rewiring host factors in infectious processes |
Nevan Krogan, PhD, MSc |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology, Genetics |
|
|
EV71 intra-host evolution, attenuation and vaccine development |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men |
Anne Luetkemeyer, MD |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance |
|
|
Identification of Cobra-specific antibodies |
Charles Craik, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Review of modeling studies used in WHO guidelines |
Nathan Lo, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Policy and Standards of Care, Systematic Reviews and Guideline Development |
|
|
Understanding the epidemiology and natural history of unrecognized Ebola virus infection |
Dan Kelly, MD, MPH |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Prevalence, incidence and risk factors for genital and rectal C. trachomatis and N. gonorrhoeae infections and antibiotic resistance in Fiji |
Deborah Dean, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance |
|
|
New Serological Measures of Infectious Disease Transmission Intensity |
Benjamin F. Arnold, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Estimating the burden of arboviruses in Uganda using age-stratified serological data |
Isabel Rodriguez Barraquer, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance |
|
|
Ebola modeling: behavior, asymptomatic infection, and contacts |
Travis Porco, PhD, MPH |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Epidemiology and Surveillance |
|
|
Investigating interactions between pesticide exposures and susceptibility to Zika virus infection in the human placenta |
Stephanie Gaw, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease, Newborn and Infant Health |
|
|
AVENIR: Assessing the impact of azithromycin on child mortality in Niger |
Thomas Lietman, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Pharmacology and Drug Treatment, Pediatrics, Newborn and Infant Health, Health Economics and Effectiveness |
|
|